Thiazolylimidazole derivatives and their use as inhibitors of microsmal triglyce ride transfer protein

Details for Australian Patent Application No. 2005210077 (hide)

Owner Merck Patent GmbH

Inventors Guedat, Philippe; Chevreuil, Olivier; Convard, Thierry

Agent Davies Collison Cave

Pub. Number AU-A-2005210077

PCT Pub. Number WO2005/074934

Priority 04/01046 04.02.04 FR

Filing date 17 January 2005

Wipo publication date 18 August 2005

International Classifications

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/074934 Priority application(s): WO2005/074934

11 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210083-Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases

2005210070-Silico-sodo-calcic glass composition